Isolation of Papillary and Reticular Fibroblasts from Human Skin by Fluorescence-activated Cell Sorting
May 7th, 2019
This manuscript describes a FACS-based protocol for isolation of papillary and reticular fibroblasts from human skin. It circumvents in vitro culture which was inevitable with the commonly used isolation protocol via explant cultures. The emanating fibroblast subsets are functionally distinct and display differential gene expression and localization within the dermis.
Overview
This manuscript presents a FACS-based protocol for isolating papillary and reticular fibroblasts directly from human skin, avoiding in vitro culture. The isolated fibroblast subsets are functionally distinct, exhibiting different gene expression and localization within the dermis.
Key Study Components
Area of Science
- Cell Biology
- Neuroscience
- Dermatology
Background
- Fibroblasts play crucial roles in skin physiology and pathology.
- Traditional isolation methods often involve in vitro culture, which can alter cell properties.
- FACS allows for the sorting of cells based on specific surface markers.
- Understanding fibroblast heterogeneity is essential for studying skin diseases.
Purpose of Study
- To develop a protocol for the direct isolation of fibroblast subsets from human skin.
- To investigate the functional differences between papillary and reticular fibroblasts.
- To provide a visual demonstration to aid in the isolation process.
Methods Used
- Preparation of full-thickness dermis from human skin.
- Separation of dermal layers using a dermatome.
- Enzymatic digestion to obtain a single-cell suspension.
- FACS sorting of fibroblast subpopulations based on surface markers.
Main Results
- Three distinct fibroblast populations were identified with different localization and gene expression.
- FAP-positive CD90-negative fibroblasts are enriched in the papillary dermis.
- FAP-positive CD90-positive and FAP-negative CD90-positive fibroblasts are more abundant in the reticular dermis.
- Adipogenic differentiation varied among the fibroblast populations.
Conclusions
- The developed protocol allows for the isolation of functionally distinct fibroblast subsets.
- This advancement enhances the study of skin pathologies.
- Future research can utilize these isolated populations to explore their roles in skin diseases.
Frequently Asked Questions
Executive Industry Relevance
Direct isolation of papillary and reticular fibroblast subsets from human skin using FACS enables precise functional analysis of dermal cell heterogeneity, critical for understanding disease mechanisms and tissue homeostasis. This capability advances early discovery by providing unmanipulated, lineage-specific human fibroblast populations for mechanistic de-risking and target validation. The protocol supports translational research by linking fibroblast function to skin pathology, informing risk-adjusted portfolio decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of fibroblast lineage-specific roles in skin disease mechanisms.
- Supports biological de-risking by isolating functionally distinct dermal cell populations.
- Facilitates functional target validation through direct ex vivo analysis of human fibroblasts.
- Improves predictive confidence in early-stage dermatological research.
Screening & Assay Development
- Provides validated, unmanipulated fibroblast subsets for downstream functional assays.
- Enhances assay reproducibility by minimizing in vitro artifact introduction.
- Enables quantitative assessment of lineage-specific gene expression and differentiation potential.
- Supports reliable evaluation of compound effects on distinct fibroblast populations.
Translational & Preclinical Research
- Aligns fibroblast subset function with disease-relevant phenotypes in skin pathology.
- Enables continuity from discovery to preclinical validation by preserving native cell characteristics.
- Supports identification of translational biomarkers linked to fibroblast lineage.
- Reduces mechanistic ambiguity in preclinical dermatology models.
Pipeline & Workflow Integration
This FACS-based isolation method integrates at the interface of early discovery and preclinical research, enabling direct hypothesis testing and functional analysis of human dermal fibroblast subsets.
- Discovery Biology: Supports mechanistic studies of fibroblast heterogeneity and lineage-specific function in skin.
- Screening: Delivers reproducible, quantitative outputs for functional and gene expression assays.
- Analytics: Provides robust readouts for comparing differentiation and gene expression across fibroblast subsets.
- Translational Research: Links ex vivo fibroblast function to disease-relevant outcomes in skin pathology.
- Enterprise Reuse: Establishes a reusable protocol for isolating primary human fibroblast populations across studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in skin disease research.
- Operational Value: Standardizes fibroblast isolation, improving reproducibility and scalability across projects.
- Strategic Value: Enables informed go/no-go decisions by providing lineage-specific functional data.
- Portfolio Impact: Supports risk-adjusted prioritization of dermatological targets and models.
Implementation Considerations
- Requires expertise in tissue handling, enzymatic digestion, and FACS operation.
- Demands access to advanced cell sorting instrumentation and analytical platforms.
- Necessitates cross-team standardization of tissue processing and marker selection.
- May require adaptation for different skin sources or disease states.
- Cell yield and viability depend on precise tissue preparation and digestion protocols.
Biopharma FAQs
Chapters in this video
0:04
Title
1:00
Sectioning of Human Skin Dermis into Papillary and Reticular Layers
2:38
Separation and Enzymatic Digestion of Epidermis and Dermis
3:52
Preparation of Single Cell Suspension and Erythrocyte Lysis
5:58
Culturing of Fibroblasts and Adipogenesis Assay
7:04
Results: FAP+CD90-, FAP+CD90+ and FAP-CD90+ Fibroblasts Differ in Dermal Localization, Gene Expression and Functionality
8:44
Conclusion
